Related Experiment Video
Updated: Oct 4, 2025
An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
Published on: June 12, 2013
Distinct molecular phenotypes involving several human diseases are induced by IFN-λ3 and IFN-λ4 in monocyte-derived
Manjarika De1, Anand Bhushan1,2, William S Grubbe3
1National Institute of Biomedical Genomics, Kalyani, West Bengal, 741251, India.
Abstract:
Human Interferon (IFN) lambda 3 (IFN-λ3) and IFN-λ4 are closely linked at the IFNL locus and show association with several diseases in genetic studies. Since they are only ~30% identical to each other, to better understand their roles in disease phenotypes, comparative studies are needed. Monocytes are precursors to macrophages (monocyte-derived macrophages; MDMs) that get differentiated under the influence of various immune factors, including IFNs. In a recent study, we characterized lipopolysaccharide-activated M1 and M2-MDMs that were differentiated in presence of IFN-λ3 or IFN-λ4. In this study, we performed transcriptomics on these M1 and M2-MDMs to further understand their molecular phenotypes. We identified over 760 genes that were reciprocally regulated by IFN-λ3 and IFN-λ4, additionally we identified over 240 genes that are significantly affected by IFN-λ4 but not IFN-λ3. We observed that IFN-λ3 was more active in M2-MDMs while IFN-λ4 showed superior response in M1-MDMs. Providing a structural explanation for these functional differences, molecular modeling showed differences in expected interactions of IFN-λ3 and IFN-λ4 with the extracellular domain of IFN-λR1. Further, pathway analysis showed several human infectious diseases and even cancer-related pathways being significantly affected by IFN-λ3 and/or IFN-λ4 in both M1 and M2-MDMs.
Insights
Interferon lambda 3 (IFN-λ3) and Interferon lambda 4 (IFN-λ4) exhibit distinct gene regulation patterns in immune cells, impacting infectious disease and cancer pathways.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Interferon lambda 3 (IFN-λ3) and Interferon lambda 4 (IFN-λ4) are genetically linked and associated with diseases.
- Despite low sequence identity (~30%), their distinct roles in disease require comparative investigation.
- Monocytes differentiate into macrophages (MDMs) influenced by immune factors like IFNs.
Purpose of the Study:
- To compare the molecular phenotypes of M1 and M2 monocyte-derived macrophages (MDMs) differentiated with IFN-λ3 or IFN-λ4.
- To elucidate the differential gene regulation and functional impacts of IFN-λ3 and IFN-λ4.
Main Methods:
- Transcriptomic analysis of M1 and M2 MDMs differentiated with IFN-λ3 or IFN-λ4.
- Molecular modeling to predict interactions with the IFN-λ receptor 1 (IFN-λR1).
- Pathway analysis to identify affected biological processes.
Main Results:
- Over 760 genes were reciprocally regulated by IFN-λ3 and IFN-λ4.
- Over 240 genes were uniquely affected by IFN-λ4.
- IFN-λ3 showed greater activity in M2-MDMs, while IFN-λ4 was more active in M1-MDMs.
- Molecular modeling revealed distinct interaction potentials with IFN-λR1.
- Pathway analysis implicated both IFNs in human infectious diseases and cancer pathways.
Conclusions:
- IFN-λ3 and IFN-λ4 exhibit distinct regulatory functions and cellular preferences in MDMs.
- Differential interactions with IFN-λR1 likely contribute to functional divergence.
- These IFNs modulate pathways relevant to infectious diseases and cancer, highlighting their complex roles in human health.
